Equities

Omnicell Inc

Omnicell Inc

Actions
  • Price (USD)27.13
  • Today's Change-0.300 / -1.09%
  • Shares traded500.17k
  • 1 Year change-55.25%
  • Beta0.7641
Data delayed at least 15 minutes, as of Apr 25 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

  • Revenue in USD (TTM)1.15bn
  • Net income in USD-20.37m
  • Incorporated2000
  • Employees3.65k
  • Location
    Omnicell Inc4220 NORTH FREEWAYFORT WORTH 76137United StatesUSA
  • Phone+1 (650) 251-6100
  • Fax+1 (650) 251-6266
  • Websitehttps://www.omnicell.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hello Group Inc (ADR)1.66bn270.16m1.09bn1.71k4.280.65633.740.65541.341.348.248.780.7488--61.51--12.625.8616.136.9741.4744.9016.857.99----0.1535---5.52-2.1931.89-7.0118.87--
Adeia Inc388.79m67.37m1.11bn130.0016.723.096.842.860.61350.61353.533.320.3357--7.872,990,677.005.822.626.582.85----17.337.83--2.330.621656.58-11.42-0.8691-52.43---3.13-24.21
PubMatic Inc267.01m8.88m1.17bn948.00269.673.9621.764.370.08660.08664.685.890.3993--0.7742281,660.301.335.772.7111.5762.8468.843.3312.58----0.000.004.1521.88-69.06--23.98--
Enfusion Inc174.54m6.33m1.19bn1.10k129.9822.1061.906.820.07160.07161.350.42081.50--6.47158,380.207.95--13.93--66.97--5.30------0.00--16.09--173.55------
Amplitude Inc276.28m-90.36m1.19bn675.00--4.03--4.32-0.775-0.7752.362.460.652--10.58409,309.60-21.33---29.82--73.97---32.71------0.00--16.05--3.23------
Taboola.com Ltd1.44bn-82.04m1.23bn1.90k--1.1785.140.8558-0.2379-0.23794.153.580.8894--5.11757,728.90-5.07---6.71--29.5628.95-5.70-2.13---4.860.1208--2.759.63-585.09---0.0149--
Phreesia Inc356.30m-136.89m1.24bn1.44k--4.92--3.47-2.51-2.516.534.460.9625--6.13247,774.00-36.98-30.60-49.67-38.0665.1963.36-38.42-42.60----0.0436--26.8428.9622.29--20.61--
MediaAlpha Inc388.15m-40.42m1.26bn137.00------3.23-0.8927-0.89278.52-0.15722.40--6.822,833,205.00-34.91-12.17-35.17-14.2817.1920.82-14.57-4.39---2.232.18---15.455.5129.91---35.22--
Omnicell Inc1.15bn-20.37m1.26bn3.65k--1.0518.801.10-0.4524-0.452425.2926.110.5175.024.16314,277.30-0.91811.73-1.122.2543.5846.69-1.782.922.22--0.32390.00-11.487.82-460.68--0.235--
Opera Ltd (ADR)397.49m169.41m1.27bn606.007.681.356.953.191.891.894.3910.690.3991--6.24--17.014.2618.354.5876.5487.0842.6216.45----0.0111--19.9119.761,026.7637.70-4.09--
Magnite Inc619.71m-159.18m1.27bn911.00--1.8015.602.05-1.18-1.184.545.060.2295--0.5757680,252.50-5.89-4.45-11.08-8.1533.8648.42-25.69-18.03---4.300.4333--7.3937.81-22.15--13.39--
E2open Parent Holdings Inc642.37m-1.30bn1.29bn4.02k--0.8477--2.01-4.29-4.292.124.980.162--4.64159,912.90-36.38---41.66--50.47---224.64-----0.12610.3934--53.26---291.31------
Meridianlink Inc303.62m-42.54m1.35bn676.00--2.7287.874.44-0.536-0.5363.786.480.2954--8.43449,137.60-4.14---4.37--64.27---14.01----0.50460.4546--5.41---3,387.40------
VTEX201.52m-13.69m1.35bn1.28k--5.62--6.71-0.0727-0.07271.081.310.5767--4.98157,805.00-3.92---4.90--69.75---6.80------0.0168--27.85--73.89------
Everbridge Inc448.79m-47.31m1.45bn1.59k--4.7591.253.22-1.17-1.1710.837.340.4172--3.52281,725.10-4.40-6.91-6.52-9.2470.8869.47-10.54-20.27----0.5433--3.9124.9922.67--15.86--
Data as of Apr 25 2024. Currency figures normalised to Omnicell Inc's reporting currency: US Dollar USD

Institutional shareholders

48.55%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20237.16m15.59%
The Vanguard Group, Inc.as of 31 Dec 20235.47m11.91%
SSgA Funds Management, Inc.as of 31 Dec 20232.01m4.38%
Champlain Investment Partners LLCas of 31 Dec 20231.51m3.29%
ClearBridge Investments LLCas of 31 Dec 20231.19m2.58%
Dimensional Fund Advisors LPas of 31 Dec 20231.07m2.33%
Pacer Advisors, Inc.as of 31 Dec 20231.06m2.30%
Geode Capital Management LLCas of 31 Dec 2023997.69k2.17%
Geneva Capital Management LLCas of 31 Dec 2023938.94k2.05%
Macquarie Investment Management Business Trustas of 31 Dec 2023893.50k1.95%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.